The ACCESS Model Turns Digital Health Into Reimbursed Care Infrastructure
Editorial revision: . Original publication and source dates are retained.
CMS has opened an outcome-aligned payment path for technology-supported chronic care. Commercial viability depends on delivering measurable outcomes through Medicare referral, care-management, and reporting workflows at a sustainable cost.
Return to insightsDigital health founders, chronic-care platforms, provider partners, Medicare operators, and healthcare investors / Reviewed 2026-07-19
Decision use
Use this brief to decide whether a digital-care product is ready to become a reimbursed, referral-connected care operation under an outcomes-based model.
This analysis uses public CMS model materials and separates published program requirements from operator interpretation. It does not predict CMS approval, payment, or clinical performance for any company.
Executive thesis
The ACCESS Model Turns Digital Health Into Reimbursed Care Infrastructure
My investment thesis is that an outcome-aligned payment route changes the business a digital-care company must operate. The company needs an accountable clinical service, a way for eligible patients to reach it, an evidence process that satisfies the actual payment terms and enough liquidity to fund care before settlement. Software engagement can support that model; it cannot substitute for its obligations.
I would evaluate the opportunity from the payment obligation backward. Identify the population and qualifying service, the organization authorized to deliver it, the evidence required and the conditions affecting collection. Then cost the complete pathway. A program can meet its clinical objective and still produce an unattractive supplier business if acquisition, care delivery, documentation or delayed payment consumes the available contribution.
Public facts
CMS says the voluntary ACCESS Model began July 5, 2026 and will run for 10 years, testing recurring outcome-aligned payments for technology-supported chronic care in Original Medicare.
The initial tracks cover early cardio-kidney-metabolic conditions, cardio-kidney-metabolic conditions, chronic musculoskeletal pain, and behavioral health conditions.
CMS reports that more than 150 organizations were accepted for the launch and that payers representing 165 million people pledged to offer ACCESS-aligned payment arrangements, many by January 1, 2028.
Operator read
Build around a defined condition and a complete care pathway: accept the referral, manage the episode, report back to the clinician, and demonstrate the risk-adjusted result.
Referral architecture becomes part of the product. The directory listing, primary-care handoff, co-management payment, structured care update, and exception loop all influence activation and trust.
Outcome pricing shifts margin risk into implementation. Weak onboarding, clinical escalation, adherence, or measurement can erase the apparent leverage of a software-heavy model.
Operating response
Translate the signal into a governed decision.
The first commitment should buy evidence on the delivery model. I would validate a bounded referral pathway with a defined receiving team, realistic capacity and a complete cost ledger. Track eligible referrals, accepted patients, completed care, required outcome evidence and collectible payment as separate stages. Attrition at each stage has a different remedy and a different owner.
A sustainable growth plan must also align the economics of the referring practice and the delivering organization. Referral effort, coordination and unresolved clinical work have costs even when they sit outside the vendor’s statement of work. Map the relevant funding route rather than assuming that participation in a CMS model gives every partner an incentive to invest. Expansion becomes credible when both sides can support the work and the result remains viable under conservative participation and collection assumptions.
Buyer implications
Founders need a Medicare operating plan, not only an ACCESS application strategy.
Provider partners should evaluate referral fit, care-update quality, patient experience, exception ownership, and whether co-management reduces or adds work.
Investors should test outcome durability and delivery cost by cohort rather than treating reimbursement eligibility as product-market fit.
Founder actions
- 01
Choose one clinical track and write the full referral-to-outcome workflow.
- 02
Build a cohort economics model that includes attrition, non-attainment, clinical labor, monitoring, and reporting.
- 03
Create an auditable outcomes dictionary before scaling enrollment.
- 04
Use the first performance period to prove repeatability, then translate that evidence into payer-aligned contracting.
Metrics that matter
Eligible referrals reaching funded care, with noncompletion reasons
Time from referral to qualifying care and first collectible payment
Risk-adjusted outcome attainment and persistence
Escalation hours and unresolved obligations relative to staffed capacity
Collected contribution and cash required after acquisition, clinical delivery and measurement
Red flags
The company has an engagement metric but no defensible clinical outcome definition.
Primary care referral, progress updates, and co-management are treated as integrations to solve after launch.
The model assumes recurring payment without modeling non-attainment, attrition, or delivery burden.
Executive questions
- 01
Which track can the organization deliver within its clinical authority, funded capacity and available working capital?
- 02
Who accepts each unresolved clinical or administrative obligation, and how is that response capacity funded?
- 03
Can the required outcome be demonstrated at a measurement cost the payment supports?
- 04
What cohort-level delivery, contribution and collection thresholds justify entering a second payment arrangement?
Primary and attributed sources
CMS sources do not endorse this analysis or its recommendations.
Related operating work
Turn the payment signal into a referral, care, evidence, and payer-expansion operating plan.
Design the reimbursement motionDiscuss the strategic decision